Medigen, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers (NCT07088822) | Medigen, Inc. | 2025-08-15 |
Track Medigen, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.